Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewBGC 20-1531 hydrochloride is a high affinity and selective EP4 antagonist (Ki = 3 nM). Exhibits >2500-fold selectivity for EP4 over EP2 and EP3. Also selective over a range of other prostanoid receptors, ion channels, transporters and enzymes. Inhibits PGE2-induced vasodilation of middle cerebral and meningeal arteries in vitro, and carotid blood flow in vivo. Orally bioavailable.
BGC 20-1531 hydrochloride is also offered as part of the Tocriscreen 2.0 Max. Find out more about compound libraries available from Tocris.
M. Wt | 529 |
Formula | C26H24N2O6S.HCl |
Storage | Desiccate at RT |
Purity | ≥98% (HPLC) |
CAS Number | 1962928-26-2 |
PubChem ID | 121513858 |
InChI Key | ZSHYZCXOFPPBMH-UHFFFAOYSA-N |
Smiles | CC(OC(C(NS(C4=CC=CC=C4C)(=O)=O)=O)=C3)=C3COC(C=C2)=CC=C2C1=NC=C(OC)C=C1.Cl |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 49.25 | 100 |
The following data is based on the product molecular weight 529. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.89 mL | 9.45 mL | 18.9 mL |
5 mM | 0.38 mL | 1.89 mL | 3.78 mL |
10 mM | 0.19 mL | 0.95 mL | 1.89 mL |
50 mM | 0.04 mL | 0.19 mL | 0.38 mL |
References are publications that support the biological activity of the product.
Sutton et al (2014) From virtual to clinical: The discovery of PGN-1531, a novel antagonist of the prostanoid EP4 receptor. Bioorg.Med.Chem.Lett. 24 2212 PMID: 24703233
If you know of a relevant reference for BGC 20-1531 hydrochloride, please let us know.
Keywords: BGC 20-1531 hydrochloride, BGC 20-1531 hydrochloride supplier, BGC20-1531, hydrochloride, PGN1531, high, affinity, selective, EP4, antagonists, orally, bioavailable, active, PGN, 1531, Prostanoid, Receptors, 5327, Tocris Bioscience
Citations are publications that use Tocris products. Selected citations for BGC 20-1531 hydrochloride include:
David et al (2022) Tumor-Derived Lysophosphatidic Acid Blunts Protective Type I Interferon Responses in Ovarian Cancer. Cancer Discov 12 1904-1921 PMID: 35552618
Perkins et al (2018) Autocrine-paracrine prostaglandin E2 signaling restricts TLR4 internalization and TRIF signaling. Nat.Immunol. 19 1309 PMID: 30397349
Do you know of a great paper that uses BGC 20-1531 hydrochloride from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review BGC 20-1531 hydrochloride and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image